Kothari Petroche (KOTHARIPET)
CyclicalFairStock Score: 51/100 — MIXED
Score breakdown: P/E: 3/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹143.92 |
| Market Cap | ₹846.92 Cr |
| P/E Ratio | 11.68 |
| ROCE | 29.99% |
| ROE | 21.37% |
| Dividend Yield | 1.39% |
| Profit Growth | 3.2% |
| Debt/Equity | 0.01 |
| Sales Growth | 0% |
| Promoter Holding | 72.22% |
| 52-Week Range | ₹94.75 — ₹155.47 |
| Sector | Chemicals & Petrochemicals |
| Book Value | ₹63.26 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
I look at Kothari Petroche through a Graham lens: price versus book and earnings, plus balance-sheet safety. At ₹143.92, market cap ₹847 Cr, P/E 11.68 and P/B 2.28 with book value ₹63.26. That is not a bargain-bin asset play, but the earnings yield is attractive if profits hold. The quality markers are the real draw: ROE 21.37%, ROCE 29.99%, and debt/equity 0.01. A business earning 30% on capital with virtually no debt usually has some pricing power, niche chemistry, or cost advantage, even in petrochemicals. Piotroski 7/9 supports improving fundamentals, and promoter holding 72.22% aligns owners with shareholders. Dividend yield 1.39% is modest but a positive. Growth is the puzzle. Five-year revenue CAGR of 21.09% shows it can compound, yet latest Sales Growth is 0.00% and Profit Growth 3.20%. The latest quarter had ₹135 Cr sales and ₹19 Cr net profit, so profitability remains healthy, but the top line has stalled. PEG 0.39 suggests the market is not paying much for growth; P/E 11.68 is reasonable. FairStock Score 51/100 mixed confirms this isn't a slam dunk. The 52-week range ₹94.75–₹155.47 shows the stock has rerated but not euphorically. If I owned it, I would demand that sales reaccelerate while ROCE stays near 30% and debt stays negligible. The moat may be modest in a cyclical petrochemical business, so I would not overpay. At this price, it looks like a reasonably valued cyclical with quality balance sheet; a watchlist candidate, not a blind buy.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer